COVID-19 presents enormous challenges to research ethics oversight. Here, we’ve begun a collection of oversight-related resources in order to best prepare our community for the operational and review concerns brought on by the viral outbreak. This list will be updated regularly; if you have a resource you think would be helpful for others in the field, let us know.

Navigate to:
PRIM&R resources
General oversight resources
Research with animals
Human subjects research

PRIM&R Resources

• COVID-19: How HRPPs are Preparing and Responding—A Discussion Forum
  Webinar
• COVID-19 Considerations for Animal Care and Use Programs
  Community Conversations
• COVID-19 Considerations for IRBs and HRPPs
  Community Conversations
• What can lessons learned from Ebola teach us about coronavirus?
  Ampersand
• Webinar Follow-Up: COVID-19—How HRPPs are Preparing and Responding
  Ampersand
• COVID-19: How HRPPs are Preparing and Responding—A Discussion Forum
  PRIM&R Online Learning
• Webinar Follow-Up: COVID-19—How HRPPs are Preparing and Responding
  Ampersand
• Scientific, Regulatory, and Ethical Issues with Experimental Treatments and Ebola Vaccines | AER14
  PRIM&R Conference Materials

General oversight resources

• COVID-19 Ethics and Policy Insights and Resources
  Berman Institute of Bioethics, JHU
• COVID-19: Developing Drugs and Biological Products for Treatment or Prevention
  FDA
• COVID-19 Research Resources
  Harvard Catalyst
• Institutional and Agency Responses to COVID-19 and Additional Resources
  Multiple institutions, via COGR
• Open peer-review platform for COVID-19 preprints
  Nature
• Research During Global Health Emergencies
  CITI Program
• Frequently Asked Questions for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19)
  DOD
• COVID-19 Discussion and Information Series
  ISBER

Research with animals

• FAQs and other resources on COVID-19 for Animal Care and Use Programs
  AAALAC
• COVID-19 Frequently Asked Questions
  Americans for Medical Progress
• Restarting Research: A Webinar to Assist the Biomedical Community in Bringing Animal-Based Research Programs Back Online
  Americans for Medical Progress
• Foundation for Bimoedical Research’s COVID-19 Resources
  Foundation for Biomedical Research
• COVID-19: What veterinarians need to know
  AVMA
• Maintaining Compliance in Unprecedented Times: Flexibilities for Compliance with the PHS Policy During the COVID-19 Pandemic
  OLAW
• Webinar on Pandemic Contingency Planning and Its Impact on Animal Care
  OLAW
• Full Webpage: COVID-19 Pandemic Contingency Planning for Animal Care and Use Programs
  OLAW
• Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19
  OLAW
• COVID-19 Pandemic Response Resources and FAQs for Animal Care and Use Programs
  OLAW

Human subjects research

• Guidance for Application of the Human Subjects Protection Regulations to Actions Taken in Response to the COVID-19 Pandemic
  OHRP
• Webinar: OHRP Guidance on Response to COVID-19
  OHRP
• Pandemic Pause: Reflections on HRPP Responses to the COVID-19 Pandemic
  AAHRPP
• Coronavirus Guidance
  Advarra
• Free Research Compliance Resources During COVID-19 Crisis
  Advarra
• IRB Review of Coronavirus and Other Emerging Infectious Disease Research: Issues to Consider
  Advarra
• Research ethics in a public health crisis
  AMA
• Resource for Organizations Conducting Research in the Developing World Amid COVID-19 Pandemic
  Bass, Berry & Sims
• Workshop: Addressing REB Review Challenges for Onsite Research in the Time of COVID-19
  Canadian Association of Research Ethics Boards (CAREB)
• COVID-19: Back to Campus (Fall 2020)
  CITI
• Best Practices on Conducting Clinical Trials during COVID-19 Webinar
  Clinical Trials Transformation Initiative
• Engaging Racial and Ethnic Minority Patient Populations in COVID-19 Clinical Trials
  Clinical Trials Transformation Initiative
• COVID-19 Ethics: Health, Inequality, and Justice
  Columbia University Division of Ethics
• DIA DIRECT: COVID-19: Experts from China Speak on Conducting Clinical Trials During the Pandemic
  DIA
• FDA Issues Guidance for Conducting Clinical Trials
  FDA
• FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
  (Updated July 7, 2020)
  FDA
• COVID-19 | HRP Helpful Information and Resource Links
  HRP
• COVID-19 Considerations for Ongoing Human Research Studies (PDF)
  HRP Consulting
• Essential information for Human Subjects Research Teams Related to COVID-19
  Johns Hopkins University
• COVID-19 Clinical Research Flyers
  Multi-Regional Clinical Trials Center and Harvard Catalyst
• Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
  NIAID
• Rapid Review of Human Subjects Research Related to the SARS-CoV-2 Pandemic
  NIH Office of Intramural Research
• Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees
  NSF
• COVID-19 and the ethical imperative of preparedness
  Nuffield Council on Bioethics (UK)
• Research in global health emergencies report
  Nuffield Council on Bioethics (UK)
• Research in the time of coronavirus: keep it ethical
  STAT
• Responsible Research During the COVID-19 Pandemic
  Verrill
• Changes to Research Made in Response to COVID-19
  WCG
• Clinical Trials in a New Era [webinar series]
  WCG